1. Home
  2. CLWT vs GTBP Comparison

CLWT vs GTBP Comparison

Compare CLWT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

HOLD

Current Price

$1.20

Market Cap

9.1M

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.75

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLWT
GTBP
Founded
1971
1965
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
8.5M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CLWT
GTBP
Price
$1.20
$0.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.7K
2.4M
Earning Date
12-30-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$14,012,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$0.54
52 Week High
$1.63
$3.85

Technical Indicators

Market Signals
Indicator
CLWT
GTBP
Relative Strength Index (RSI) 56.33 51.68
Support Level $1.13 $0.65
Resistance Level $1.23 $0.75
Average True Range (ATR) 0.08 0.08
MACD -0.00 -0.01
Stochastic Oscillator 83.33 42.81

Price Performance

Historical Comparison
CLWT
GTBP

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: